TP306605 MAP kinase p38 alpha / MAPK14 (transcript variant 2)

Recombinant protein of human mitogen-activated protein kinase 14 (MAPK14), transcript variant 2

Search for all "MAP kinase p38 alpha / MAPK14"

20 µg / $748.00
Delivery Time: 2-3 working days*
(*) valid for US customers only

Quick Overview

MAP kinase p38 alpha / MAPK14

Product Description for MAP kinase p38 alpha / MAPK14

MAP kinase p38 alpha / MAPK14.

Properties for MAP kinase p38 alpha / MAPK14

Product Category Proteins & Growth Factors
Target Category
Quantity 20 µg
Synonyms CSBP, CSBP1, CSBP2, CSPB1, Cytokine suppressive anti-inflammatory drug-binding protein, MAX-interacting protein 2, MXI2, Mitogen-activated protein kinase 14, SAPK2A, p38 alpha
Molecular weight 41.1 kDa
Source HEK293 cells
Species (Protein) Human
Shipping to Europe, USA/Canada
PDF datasheet View Datasheet
Manufacturer OriGene Technologies, Inc.

Datasheet Extract

Immunogen
Swiss Prot Num:
Q16539
Purity > 80 %
Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps.
Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining.
Add. information Tag: C-terminal MYC/DDK
Storage Store at -80C. Avoid repeated freeze-thaw cycles. Stable for at least 3 months from receipt of products under proper storage and handling conditions.
Format
Buffer System:
25 mM Tris.HCl, pH 7.3, 100 mM glycine, 10% glycerol.
Purity:
>80%
Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps.
Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining.
  • LinkedIn